Ibai Tamayo
- Pharmaceutical Science top 10%
-
- Immunotherapy and Immune Responses 3
-
- Diabetes Management and Research 5
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
-
- Diabetes and associated disorders 5
-
- Blood Pressure and Hypertension Studies 3
-
- Blood Coagulation and Thrombosis Mechanisms 3
-
- Frailty in Older Adults 2
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Carlos GamazoJuan M. IracheJuan José LasarteCristina MansillaJavier Ochoa‐RepárazBerta IbáñezJosé HermidaJuliana de Souza Rebouças
- Partner nations
- SpainUnited StatesDenmark
In The Last Decade
Ibai Tamayo
31 papers receiving 378 citations
Peers
Comparison fields: 5 of 75
- Pharmaceutical Science 45
- Immunology 127
- Endocrinology 25
- Immunology and Allergy 28
- Microbiology 25
Countries citing papers authored by Ibai Tamayo
This map shows the geographic impact of Ibai Tamayo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibai Tamayo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibai Tamayo more than expected).
Fields of papers citing papers by Ibai Tamayo
This network shows the impact of papers produced by Ibai Tamayo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibai Tamayo. The network helps show where Ibai Tamayo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ibai Tamayo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 6 | |
| 14 | 2018 | 1 | |
| 15 | 2018 | 5 | |
| 16 | 2018 | 7 | |
| 17 | 2016 | 13 | |
| 18 | 2016 | 30 | |
| 19 | 2014 | 2 | |
| 20 | 2014 | 8 |
About Ibai Tamayo
Ibai Tamayo is a scholar working on Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism and Hematology, having authored 32 papers that have together received 381 indexed citations. Recurring topics across this work include Diabetes Management and Research (5 papers), Diabetes and associated disorders (5 papers), Blood Pressure and Hypertension Studies (3 papers), Immunotherapy and Immune Responses (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Frailty in Older Adults (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Pharmaceutical Science (45 citations), Immunology (127 citations) and Endocrinology (25 citations). Ibai Tamayo has collaborated with scholars based in Spain, United States and Denmark. Frequent co-authors include Carlos Gamazo, Juan M. Irache, Juan José Lasarte, Cristina Mansilla, Javier Ochoa‐Repáraz, Berta Ibáñez, José Hermida, Juliana de Souza Rebouças, María José Goñi and Ana I. Camacho. Their work appears in journals such as Blood, The FASEB Journal and International Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.